Production of interleukin-18 in human tuberculosis

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 234-239

  Vankayalapati, Ramakrishna ^a   Wizel, Benjamin ^a   Weis, Stephen E ^c   Samten, Buka ^a   Girard, William M ^b   Barnes, Peter F ^a,b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Health Science Center   (United States)

^c University of North Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 18;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PLEURA FLUID; PRIORITY JOURNAL; TUBERCULOSIS;

HUMANS; INTERFERON TYPE II; INTERLEUKIN-18; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MACROPHAGES, ALVEOLAR; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0033930337     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315656     Document Type: Article

References (32)

1. 1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MD. Global burden of tuberculosis - estimated incidence, prevalence, and mortality by country. JAMA 1999;282:677-86.
2. 2. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon-gamma gene disrupted mice. J Exp Med 1993;178:2243-7.
3. 3. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
4. 4. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996;335:1956-61.
5. 5. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-γ receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9.
6. 6. Sanchez FO, Rodriguez JI, Agudelo G, Garcia LF. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 1994;62:5673-8.
7. 7. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:3231-4.
8. 8. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ. Cross-modulation by transforming growth factor β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon γ production. Proc Natl Acad Sci USA 1996;93:3193-8.
9. 9. Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998;70:281-312.
10. 10. Okamura H, Hsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
11. 11. Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156:4274-9.
12. 12. Kohno K, Kataoka J, Ohtsuki T, et al. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997;158:1541-50.
13. 13. Kawakami K, Qureshi MH, Zhang T, Okamura H, Kurimoto M, Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ-production. J Immunol 1997;159:5528-34.
14. 14. Takeda K, Tsutsuit H, Yoshimoto T, et al. Defective NK cell activity and TH1 response in IL-18-deficient mice. Immunity 1998;8:383-90.
15. 15. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ-production. J Immunol 1998;161:3400-7.
16. 16. Wei X, Leung BP, Niedbala W, et al. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J Immunol 1999;163:2821-8.
17. 17. Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18 gene-disrupted mice. Infect Immun 1999;67:2585-9.
18. 18. Ahn H, Maruo S, Tomura M, et al. A mechanism underlying synergy between IL-12 and IFN-γ inducing factor in enhanced production of IFN-γ. J Immunol 1997;159:2125-31.
19. +, and CD4 CD8 T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18. J Immunol 1998;160:3759-65.
20. 20. Garcia VE, Uyemura K, Sieling PA, et al. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol 1999;162:6114-21.
21. 21. Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and interferon-gamma in tuberculous pleuritis. J Immunol 1990;145:149-54.
22. 22. Xu D, Chan WL, Leung BP, et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 1998;188:1485-92.
23. 23. Mastroeni P, Clare S, Khan S, et al. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 1999;67:478-83.
24. 24. Dybing JK, Walters N, Pascual DW. Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections. Infect Immun 1999;67:6242-8.
25. 25. Bohn E, Sing A, Zumbihl R, et al. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 1998;160:299-307.
26. 26. Klein SA, Ottmann OG, Ballas K, et al. Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction. Cytokine 1999;11:451-8.
27. 27. Hirsch CS, Ellner JJ, Russell DG, Rich EA. Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994;152:743-53.
28. 28. Zhang M, Gately MK, Wang E, et al. Interleukin-12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-9.
29. 29. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996;64: 1351-6.
30. 30. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol 1995;154:465-73.
31. 31. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β. Proc Natl Acad Sci USA 1997;94:3926-31.
32. 32. Rogge L, Barberis-Maino L, Biffi M, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997;185:825-31.